KATERINA SAFONOVA: Open Payments
NPI 1528568011 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 16 payments from 8 companies in 2025. Trend: 2023 $406 · 2024 $446 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $400 |
| Ardelyx, Inc. | 4 | $191 |
| Novo Nordisk Inc | 4 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ABBVIE INC. | 1 | $28 |
| Amgen Inc. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: REXULTI, IBSRELA, Auvelity, Rybelsus, Ozempic, LINZESS, OTEZLA, ACCRUFER.
Industry payments across NY — which companies pay providers there.
